CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $70.25M, above the global median of $16.24M
- FinancialsAltman Z-Score 2.78: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.12BCNY908.04M · vs all stocks (USD)
Revenue (TTM)
1.18BCNY174.46M · vs all stocks (USD)
Profit Margin
-6.76%Beta
0.0020xvs all stocks
52-Week Change
24.66%vs all stocks
Market Capitalization
6.12BCNY908.04M · vs all stocks (USD)
Enterprise Value
7.09BCNY1.05B · vs all stocks (USD)
Forward P/E
16.17xPrice to Sales (TTM)
5.55xPrice to Book (MRQ)
2.50xEnterprise to Revenue
6.03xEnterprise to EBITDA
96.11xGross Margin
56.88%Profit Margin
-6.76%Operating Margin
38.42%Return on Assets (TTM)
-0.39%Return on Equity (TTM)
-3.02%Revenue (TTM)
1.18BCNY174.46M · vs all stocks (USD)
Revenue per Share (TTM)
1.90CNYUpdated Aug 19, 2026Quarterly Revenue Growth
18.80%Gross Profit (TTM)
486.45MCNY72.14M · vs all stocks (USD)
EBITDA (TTM)
65.06MCNY9.65M · vs all stocks (USD)
Net Income (TTM)
-79.49MCNY-11.79M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
577.20%Operating Cash Flow (TTM)
729.10MCNY108.13M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
473.71MCNY70.25M · vs all stocks (USD)
Payout Ratio
0.00%Minority Interest (Equity)
91.66MCNYFY2025 · Dec 31, 2025Revenue
1.12BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
726.95MCNYFY2025 · Dec 31, 2025Gross Profit
390.38MCNYFY2025 · Dec 31, 2025Operating Income
-54.66MCNY-8.11M · vs all stocks (USD)
Pre-tax Income
-159.23MCNYFY2025 · Dec 31, 2025Income Tax Expense
12.67MCNYFY2025 · Dec 31, 2025Net Income
-171.90MCNYFY2025 · Dec 31, 2025EBIT
-121.15MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
65.06MCNYFY2025 · Dec 31, 2025Research & Development
59.16MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
202.29MCNYFY2025 · Dec 31, 2025Other Operating Expenses
19.68MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
11.48MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
38.08MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.2700CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.2700CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
619.40MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
619.40MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-171.90MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
4.66MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
334.19MCNYFY2025 · Dec 31, 2025Free Cash Flow
45.29MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
534.03MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-171.90MCNYFY2025 · Dec 31, 2025Other Non-cash Items
41.32MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
486.88MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-22.11MCNYFY2025 · Dec 31, 2025Capital Expenditures
-288.90MCNYFY2025 · Dec 31, 2025Purchase of Investments
-6.57MCNYFY2025 · Dec 31, 2025Sale of Investments
14.73MCNYFY2025 · Dec 31, 2025Other Investing Activity
9.46MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-271.28MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
891.56MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.05BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-47.70MCNYFY2025 · Dec 31, 2025Other Financing Charges
268.08MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
57.13MCNYFY2025 · Dec 31, 2025Shares Outstanding
611.69MSharesUpdated Aug 19, 2026Float Shares
284.38MSharesUpdated Aug 19, 2026% Held by Insiders
56.66%vs all stocks
% Held by Institutions
1.51%vs all stocks
Total Cash (MRQ)
575.01MCNY85.27M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.9400CNYUpdated Aug 19, 2026Total Debt (MRQ)
1.06BCNY156.94M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3924xCurrent Ratio (MRQ)
1.23xBook Value per Share (MRQ)
4.27CNYUpdated Aug 19, 2026Total Assets
4.39BCNY651.22M · vs all stocks (USD)
Total Current Assets
1.65BCNYFY2025 · Dec 31, 2025Total Liabilities
1.78BCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.74BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
432.97MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.35BCNYFY2025 · Dec 31, 2025Cash
534.03MCNYFY2025 · Dec 31, 2025Cash Equivalents
12.52MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
546.55MCNYFY2025 · Dec 31, 2025Accounts Receivable
619.08MCNYFY2025 · Dec 31, 2025Inventory
232.67MCNYFY2025 · Dec 31, 2025Accounts Payable
339.46MCNYFY2025 · Dec 31, 2025Short-term Debt
801.51MCNYFY2025 · Dec 31, 2025Other Current Liabilities
30.45MCNYFY2025 · Dec 31, 2025Long-term Debt
183.55MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
4.27MCNYFY2025 · Dec 31, 2025Common Stock (Book)
611.69MCNYFY2025 · Dec 31, 2025Retained Earnings
1.49BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.61BCNY386.71M · vs all stocks (USD)
Treasury Stock
0.00CNYFY2025 · Dec 31, 202552-Week Low
7.74CNYUpdated Aug 19, 202652-Week High
36.24CNYUpdated Aug 19, 202652-Week Change
24.66%vs all stocks
Beta
0.0020xvs all stocks
50-Day MA
11.33CNYUpdated Aug 19, 2026200-Day MA
16.74CNYUpdated Aug 19, 2026Avg 10-Day Volume
12.84MSharesUpdated Aug 19, 2026Avg 30-Day Volume
15.24MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
-0.1300CNYUpdated Aug 19, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.57Profit Margin: -0.07
Financial Health
Altman Z-Score 2.78: safe zoneNotable
Altman Z-Score: 2.78
High earnings qualityNotable
Earnings Quality Score: 1.36
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $70.25M, above the global median of $16.24MNotable
Levered free cash flow (USD): 70,250,625.901Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Wuhan Keqian Biology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Hangzhou Biotest Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
China Isotope & Radiation Corporation
Tier 1ProductionApproval-Gated PipelineRuleFlow
Wuhan Huakang Century Medicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shandong Wit Dyne Health Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hubei Biocause Heilen Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
LB Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
L&C Bio Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Pharma Resources Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
DNA Link Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Xinjiang Zhundong Petroleum Technology Co., Ltd.
2 interpretationsPartial Recovery After Sharp DeclineUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Hefei Urban Construction Group Co., Ltd.
2 interpretationsPartial Recovery After Sharp DeclineUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Shenzhen Kstar Science and Technology Co., Ltd.
2 interpretationsPartial Recovery After Sharp DeclineUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated